Patents by Inventor Lawrence T. Friedhoff

Lawrence T. Friedhoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
    Patent number: 9572890
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: February 21, 2017
    Assignee: MITOTECH SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • COSMETIC COMPOSITIONS OF MITOCHONDRIALLY TARGETED ANTIOXIDANTS
    Publication number: 20160361245
    Abstract: Dislosed are compositions comprising SkQ1 for protection of the skin from damage caused by free radicals and/or re active oxygen species.
    Type: Application
    Filed: February 25, 2015
    Publication date: December 15, 2016
    Applicant: MITOTECH SA
    Inventors: VALERIYA VLADIMIROVNA PELEKH, Valeriy Vasilieveech Lyandin, Anna Vladimirovna Shibaeva, Maxim Vladimirovich Skulachev, Lawrence T Friedhoff
  • ORAL FORMULATIONS OF MITOCHONDRIALLY-TARGETED ANTIOXIDANTS AND THEIR PREPARATION AND USE
    Publication number: 20160038603
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Application
    Filed: October 20, 2015
    Publication date: February 11, 2016
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
    Patent number: 9192676
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: November 24, 2015
    Assignee: MITOTECH SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Andrey A. Zamyatnin, Eugeny S. Efremov, Innokentiy V. Skulachev, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • ORAL FORMULATIONS OF MITOCHONDRIALLY-TARGETED ANTIOXIDANTS AND THEIR PREPARATION AND USE
    Publication number: 20150025043
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Application
    Filed: June 4, 2012
    Publication date: January 22, 2015
    Applicant: Mitotech SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Andrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • Cholinesterase inhibitors to treat disorders of attention
    Patent number: 7105540
    Abstract: The present invention provides novel methods of treating disorders of attention or improving attention in humans by administering an effective amount of a cholinesterase inhibitor.
    Type: Grant
    Filed: September 24, 2002
    Date of Patent: September 12, 2006
    Assignee: Eisai Co. Ltd.
    Inventors: Lawrence T. Friedhoff, Paul J. Tiseo, Sharon L. Rogers
  • Cholinesterase inhibitors to treat disorders of attention
    Publication number: 20030055040
    Abstract: The present invention provides novel methods of treating disorders of attention or improving attention in humans by administering an effective amount of a cholinesterase inhibitor.
    Type: Application
    Filed: September 24, 2002
    Publication date: March 20, 2003
    Inventors: Lawrence T. Friedhoff, Paul J. Tiseo, Sharon L. Rogers
  • Use of cholinesterase inhibitors to treat disorders of attention
    Patent number: 6455544
    Abstract: The present invention provides novel methods of treating disorders of attention or improving attention in humans by administering an effective amount of a cholinesterase inhibitor.
    Type: Grant
    Filed: March 3, 1998
    Date of Patent: September 24, 2002
    Assignee: Eisai Co. Ltd.
    Inventors: Lawrence T. Friedhoff, Paul J. Tiseo, Sharon L. Rogers
  • Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist
    Patent number: 5066480
    Abstract: A method is provided for preventing reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A.sub.2 receptor antagonist.
    Type: Grant
    Filed: April 11, 1988
    Date of Patent: November 19, 1991
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Martin L. Ogletree, William A. Schumacher, Gary J. Grover, Lawrence T. Friedhoff
  • Method of treating skin injuries using thromboxane A.sub.2 receptor antagonists
    Patent number: 4925873
    Abstract: A method for treating skin injuries is provided by administering a thromboxane A.sub.2 receptor antagonist systemically or topically to the skin area to be treated.
    Type: Grant
    Filed: September 1, 1988
    Date of Patent: May 15, 1990
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Lawrence T. Friedhoff, Laura L. Bolton